Identifying Biological Markers for Severe Depression
Completed
Conditions studied: Major Depressive Disorder
In brief
The primary objective of this study is to investigate the biological components of major depression. The investigators are particularity interested in genetic variation and how it contributes to cortisol (because cortisol is higher in severe depression than mild depression or healthy controls) and how it contributes to clinical symptoms, especially suicidal ideation/behavior and psychosis.
Key facts
- Study ID
- NCT01831882
- Run by
- Stanford University
- People needed
- 210
- Starts
- 2013-07-01
- Expected to finish
- 2020-08-01
- Last updated by the study team
- 2020-08-21
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.
Where it is running
- University of California, Irvine — Irvine, California, United States
- Stanford University, Department of Psychiatry and Behavioral Sciences — Stanford, California, United States
- Weill Cornell Medical College — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.